Profile of Medical Prescriptions and Potential Risks to the Safety of Cancer Patients in the Chemotherapy Sector of Ophir Loyola Hospital. Belém, Pará

Orenzio Soler, Giovanny Almeida dos Santos, R. Andrade, A. Cei, Celso da Silva Mascarenhas, Ester Roseli Baptista
{"title":"Profile of Medical Prescriptions and Potential Risks to the Safety of Cancer Patients in the Chemotherapy Sector of Ophir Loyola Hospital. Belém, Pará","authors":"Orenzio Soler, Giovanny Almeida dos Santos, R. Andrade, A. Cei, Celso da Silva Mascarenhas, Ester Roseli Baptista","doi":"10.17921/2447-8938.2020V22N1P87-93","DOIUrl":null,"url":null,"abstract":"Abstract \nThe schedule and therapeutic cycle for the treatment of malignancies involves the simultaneous use of distinct drugs, including antineoplastics and adjuvants, depending on the tumor to be treated, varying according to the treatment protocol. Studies demonstrate the problem of the high potential severity associated with prescriptions errors. This work aimed to know the profile of medical prescriptions in the chemotherapy sector of Ophir Loyola Hospital, aiming to identify potential problems related to the  user safety. This is an exploratory, descriptive, quantitative and qualitative retrospective cross-sectional study, with a temporal cut from January to March 2017, through data collection in prescriptions and prospective participatory observation in the dispensation and administration in the period from April to June 2017. A total of 1,034 prescriptions were analyzed with 2,068 prescribed medications, where the mean error was 7.67 per prescription, of which: 90 (8.70%) did not inform the diluent to be used; 154 (14.89%) did not report the volume of the diluent and did not contain the infusion time; 234 (22.63%) did not inform the therapeutic scheme that would be used by the user; 247 (23.89%) did not indicate the number of the administration cycle; 374 (36.17%) did not indicate the interval between these cycles. No dispensing and administration errors were found. It can be inferred that there are shortcomings in the elaboration of the prescription, being necessary interventions that improve them, aiming to improve the quality of the service provided, as well as, to provide the user safety. \nkeywords: Public Health. Medical Oncology. Pharmacy Service, Hospital. Drug Prescriptions. Patient Safety. \nResumo \nO esquema e o ciclo terapeutico para o tratamento das neoplasias envolvem o uso simultâneo de distintos medicamentos, incluindo antineoplasicos e adjuvantes, dependendo do tumor a ser tratado, variando conforme o protocolo de tratamento. Estudos demonstram o problema da alta gravidade potencial associada a estes erros. Este trabalho teve como objetivo conhecer o perfil de prescricoes medicas no setor de quimioterapia do Hospital Ophir Loyola, visando identificar potenciais problemas relacionados com a seguranca do usuario. Trata-se de um estudo exploratorio, descritivo, retrospectivo para a analise de prescricoes medicas e prospectivo para a observacao participativa do processo de dispensacao e administracao de medicamentos antineoplasicos no Servico de Quimioterapia da Farmacia Hospitalar, realizado entre abril e junho de 2017.  Foram analisadas 1.034 prescricoes com 2.068 medicamentos prescritos, onde a media de erros foi de 7,67 por prescricao, sendo que: 90 (8,70%) nao informavam o diluente a ser utilizado; 154 (14,89%) nao informavam o volume do diluente e nao continham o tempo de infusao; 234 (22,63%) nao informavam o esquema terapeutico que seria utilizado pelo usuario; 247 (23,89%) nao indicavam o numero do ciclo de administracao; 374 (36,17%) nao indicavam o intervalo entre esses ciclos. Nao foram encontrados erros de dispensacao e de administracao. Pode-se inferir que existem falhas na elaboracao da prescricao, sendo necessarias intervencoes que aprimorem as mesmas, visando melhorar a qualidade do servico prestado, bem como, proporcionar a seguranca do usuario. \nPalavras-chave: Saude Publica. Oncologia. Servico de Farmacia Hospitalar. Drug prescriptions Patient Safety.","PeriodicalId":15873,"journal":{"name":"Journal of Health Science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17921/2447-8938.2020V22N1P87-93","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract The schedule and therapeutic cycle for the treatment of malignancies involves the simultaneous use of distinct drugs, including antineoplastics and adjuvants, depending on the tumor to be treated, varying according to the treatment protocol. Studies demonstrate the problem of the high potential severity associated with prescriptions errors. This work aimed to know the profile of medical prescriptions in the chemotherapy sector of Ophir Loyola Hospital, aiming to identify potential problems related to the  user safety. This is an exploratory, descriptive, quantitative and qualitative retrospective cross-sectional study, with a temporal cut from January to March 2017, through data collection in prescriptions and prospective participatory observation in the dispensation and administration in the period from April to June 2017. A total of 1,034 prescriptions were analyzed with 2,068 prescribed medications, where the mean error was 7.67 per prescription, of which: 90 (8.70%) did not inform the diluent to be used; 154 (14.89%) did not report the volume of the diluent and did not contain the infusion time; 234 (22.63%) did not inform the therapeutic scheme that would be used by the user; 247 (23.89%) did not indicate the number of the administration cycle; 374 (36.17%) did not indicate the interval between these cycles. No dispensing and administration errors were found. It can be inferred that there are shortcomings in the elaboration of the prescription, being necessary interventions that improve them, aiming to improve the quality of the service provided, as well as, to provide the user safety. keywords: Public Health. Medical Oncology. Pharmacy Service, Hospital. Drug Prescriptions. Patient Safety. Resumo O esquema e o ciclo terapeutico para o tratamento das neoplasias envolvem o uso simultâneo de distintos medicamentos, incluindo antineoplasicos e adjuvantes, dependendo do tumor a ser tratado, variando conforme o protocolo de tratamento. Estudos demonstram o problema da alta gravidade potencial associada a estes erros. Este trabalho teve como objetivo conhecer o perfil de prescricoes medicas no setor de quimioterapia do Hospital Ophir Loyola, visando identificar potenciais problemas relacionados com a seguranca do usuario. Trata-se de um estudo exploratorio, descritivo, retrospectivo para a analise de prescricoes medicas e prospectivo para a observacao participativa do processo de dispensacao e administracao de medicamentos antineoplasicos no Servico de Quimioterapia da Farmacia Hospitalar, realizado entre abril e junho de 2017.  Foram analisadas 1.034 prescricoes com 2.068 medicamentos prescritos, onde a media de erros foi de 7,67 por prescricao, sendo que: 90 (8,70%) nao informavam o diluente a ser utilizado; 154 (14,89%) nao informavam o volume do diluente e nao continham o tempo de infusao; 234 (22,63%) nao informavam o esquema terapeutico que seria utilizado pelo usuario; 247 (23,89%) nao indicavam o numero do ciclo de administracao; 374 (36,17%) nao indicavam o intervalo entre esses ciclos. Nao foram encontrados erros de dispensacao e de administracao. Pode-se inferir que existem falhas na elaboracao da prescricao, sendo necessarias intervencoes que aprimorem as mesmas, visando melhorar a qualidade do servico prestado, bem como, proporcionar a seguranca do usuario. Palavras-chave: Saude Publica. Oncologia. Servico de Farmacia Hospitalar. Drug prescriptions Patient Safety.
Ophir Loyola医院化疗部门癌症患者用药处方及潜在安全风险分析贝伦,帕拉
恶性肿瘤治疗的时间表和治疗周期包括同时使用不同的药物,包括抗肿瘤药物和佐剂,这取决于要治疗的肿瘤,根据治疗方案而变化。研究表明,与处方错误相关的高潜在严重性问题。这项工作旨在了解Ophir Loyola医院化疗部门的医疗处方概况,旨在发现与用户安全相关的潜在问题。本研究是一项探索性、描述性、定量定性的回顾性横断面研究,时间为2017年1月至3月,通过2017年4月至6月期间处方数据收集和前瞻性参与性配药观察。共分析1034张处方、2068种药物,平均误差为7.67张/张,其中:90张(8.70%)未告知使用的稀释剂;154例(14.89%)未报告稀释液的体积,也未包含输注时间;234家(22.63%)未告知用户将采用的治疗方案;247例(23.89%)未注明用药周期数;374例(36.17%)未指出周期之间的间隔。未发现配药和给药错误。可以推断,处方的制定存在缺陷,这是必要的干预措施,旨在改善所提供的服务质量,以及为用户提供安全。关键词:公共卫生;医学肿瘤学。医院药房药物处方。患者安全。当肿瘤发生时,需要同时使用不同的药物,包括抗肿瘤药物、佐剂、依赖于肿瘤的药物、不同的符合治疗方案的药物。研究表明,数据存在问题,并存在潜在的关联和错误。在洛约拉医院的医疗保健部门,我们有一个共同的目标,即完成医生的处方,并确定潜在的问题,亲属关系和安全问题。本研究采用探索性、描述性、回顾性分析、处方性、前瞻性、观察性、参与性等方法研究抗肿瘤药物的处方、用药、管理过程,并于2017年6月完成。本研究分析了1.034种处方和2.068种药物处方,其中有7种药物处方,67种不良处方,90种(8.70%)未发现稀释剂和药物利用的信息;154例(14.89%)未发现体积稀释剂的信息,未发现注入速度的连续性;234例(22,63%)未收到关于使用常规方法治疗的信息;247例(23,89%)未发现有行政管理方面的问题;374例(36,17%)未发现间隔性心肌梗死。任何形式都不能避免行政管理上的错误。在现有的制度中,必须有详细规定的数据,必要的干预措施,必要的干预措施,必要的干预措施,必要的干预措施,必要的干预措施,必要的干预措施,必要的干预措施,必要的干预措施,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务,必要的服务。palavras - have:沙特Publica。Oncologia。服务局医院。药物处方患者安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Health Science
Journal of Health Science 医学-毒理学
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信